Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Supramarginal Resection in Glioblastoma

NCT04243005

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Odense University Hospital Odense, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Kuopio University Hospital Kuopio, Finland
View all 17 locations
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation

NCT04969887

Conditions
Advanced Biliary Tract Cancer, Female Reproductive System Neoplasm, Female Urogenital Diseases, +14 more
Locations
  • Border Medical Oncology Unit Albury, New South Wales, Australia
  • Orange Health Service Orange, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

NCT06346067

Conditions
Advanced or Metastatic NRAS-mutant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • The Melanoma and Skin Care Institute Englewood, Colorado, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details

Related conditions